L515-0473 Screening compound: 1-[2-(4-fluorophenyl)acetyl]-N-{[2-(thiophen-2-yl)-1,3-thiazol-4-yl]methyl}piperidine-4-carboxamide

L515-0473 Screening compound: 1-[2-(4-fluorophenyl)acetyl]-N-{[2-(thiophen-2-yl)-1,3-thiazol-4-yl]methyl}piperidine-4-carboxamide
L515-0473 Screening compound: 1-[2-(4-fluorophenyl)acetyl]-N-{[2-(thiophen-2-yl)-1,3-thiazol-4-yl]methyl}piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L515-0473
1-[2-(4-fluorophenyl)acetyl]-N-{[2-(thiophen-2-yl)-1,3-thiazol-4-yl]methyl}piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L515-0473

Molecular Formula

C22H22FN3O2S2 (C22 H22 FN3 O2 S2)

Compound Name

1-[2-(4-fluorophenyl)acetyl]-N-{[2-(thiophen-2-yl)-1,3-thiazol-4-yl]methyl}piperidine-4-carboxamide

IUPAC name

1-[2-(4-fluorophenyl)acetyl]-N-{[2-(thiophen-2-yl)-13-thiazol-4-yl]methyl}piperidine-4-carboxamide

SMILES

O=C(Cc(cc1)ccc1F)N(CC1)CCC1C(NCc1csc(-c2cccs2)n1)=O

InChI

InChI=1S/C22H22FN3O2S2/c23-17-5-3-15(4-6-17)12-20(27)26-9-7-16(8-10-26)21(28)24-13-18-14-30-22(25-18)19-2-1-11-29-19/h1-6,11,14,16H,7-10,12-13H2,(H,24,28)

InChI Key

UFLREGLVLRNLNN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15129058

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

443.57

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.631

Distribution Coefficient, logD

3.631

Water Solubility, LogSw

-3.77

Polar Surface Area

52.020

Acid Dissociation Constant (pKa)

13.60

Base Dissociation Constant (pKb)

5.79

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

L515-0473 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

KRAS-Targeted Library (16000 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L515-0473 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L515-0473?
Check Price and Availability of L515-0473, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L515-0473 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L515-0473
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L515-0473
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L515-0473 available by request